Big pharmaceutical companies have signed an agreement to tackle the spread of superbugs as the UN prepares to discuss antimicrobial resistance.
Drugmakers including Johnson & Johnson, Pfizer and AstraZeneca said the world faced a “staggering threat” from drug-resistant superbugs and agreed to abide by a voluntary code of conduct designed to address the problem.
Antimicrobial resistance describes the phenomenon where antibiotics and other infection-fighting drugs no longer work effectively because bacteria have developed the ability to fight back.
您已閱讀23%（550字），剩餘77%（1812字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。